retatrutide triple agonist glp-1 gip glucagon phase 2 obesity Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset ✨ Retatrutide: The Next Evolution

PMID: 30227129

The solution remained clear

GHRP-6 and Hexarelin are earlier ghrelin-receptor agonists that act on the same receptor as Ipamorelin but trigger broader endocrine responses, including cortisol, prolactin, and ACTH elevations, which limits their usefulness as clean ghrelin-pathway reference tools

GHRP-6 may cause weight and adipose tissue gain if insulin is present

Current Research or Industry Status (2026) The scientific community is highly focused on intracellular metabolic regulators as the next frontier in longevity and obesity research

PlexusDx connects patients with providers who assess metabolic history, baseline health markers, and contraindications before prescribing compounded GLP-1 from licensed 503A pharmacies